← Open Payments lookup

ANDREAS SIDIROPOULOS: Open Payments

NPI 1871525832 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$722,449 in 580 payments from 7 companies in 2025. Trend: 2023 $431,959 · 2024 $558,499 · 2025 $722,449

Speaker / faculty: $516,944Travel & lodging: $146,044Consulting: $28,453Honoraria: $18,988Food & beverage: $12,020
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.229$282,661
ABBVIE INC.130$135,980
E.R. Squibb & Sons, L.L.C.76$114,381
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)82$114,238
Alkermes, Inc.44$54,143
Axsome Therapeutics, Inc.18$21,022
Otsuka America Pharmaceutical, Inc.1$24

Products named: FANAPT, VRAYLAR, CAPLYTA, COBENFY, LYBALVI, Auvelity, ARISTADA, REXULTI.

Industry payments across MI — which companies pay providers there.